Details of the Drug

General Information of Drug (ID: DMKLCLO)

Drug Name
DP-1038
Indication
Disease Entry ICD 11 Status REF
Neuroendocrine cancer 2B72.1 Phase 1 [1]
Cross-matching ID
TTD ID
D0UC5C

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)